Avdarna Therapeutics

Avdarna Therapeutics is an Australian biotechnology company specializing in the development of circular RNA (circRNA) technologies for vaccines and therapeutic applications. Spun out from the University of Queensland and the Australian National University, the company leverages a proprietary platform to create highly stable and potent RNA molecules that overcome the limitations of traditional linear mRNA. Their approach aims to provide longer-lasting protein expression and improved safety profiles across a range of indications, including infectious diseases and oncology. Avdarna is backed by prominent venture capital firms like Brandon Capital and Uniseed to advance its pipeline toward clinical validation. The company's technology represents a significant evolution in the field of RNA-based medicine, offering potential advantages in manufacturing and delivery.